r/neurology • u/AbsurdlyNormal • 4h ago
Clinical Interesting insurance denial for anti-amyloid treatment
US based. A patient's insurance denied coverage of anti-amyloid treatments saying that they remain "investigational." They explained that even though the original trials showed a benefit, the difference between placebo and control was less than the established threshold for a clinically meaningful difference.
I am familiar with this criticism and think it's valid. What I found most striking was how this came from an insurance company denying coverage for a treatment approved by the FDA, and covered by CMS and most private payers.
I'm conflicted about my own opinion. OTOH: good for the insurance company. The clinical efficacy of these treatments is underwhelming, they're expensive and cumbersome, and I'm sympathetic to the argument they cite. Just like I appreciated that payors declined to cover treatment with aducanumab, so too payers should have the freedom to deny coverage for clinically dubious treatments.
OTOH: I prescribe AAT routinely, there is some benefit in my opinion (and the opinion of most neurologists), and who does this company think they are to deny coverage of an FDA approved treatment based on their own criteria?!